Monsanto Roundup trial: First lawsuit alleging glyphosate-cancer link goes to jury

| | August 8, 2018

A trial in which a school groundskeeper alleged that his use of Monsanto’s Roundup weed killer caused his terminal cancer will go to a California jury after lawyers for both sides delivered their closing arguments on [August 7th.]

Groundskeeper Dewayne Johnson is one of more than 5,000 plaintiffs across the United States who claim Monsanto’s glyphosate-containing herbicides, including the widely-used Roundup, cause cancer. His case, the first to go to trial, began in San Francisco’s Superior Court of California four weeks ago.

Johnson’s lawyer Brent Wisner on [August 7th] urged jurors to hold Monsanto liable and punish them with a verdict he said would “actually change the world.” Wisner claimed Monsanto knew about glyphosate’s cancer risk, but decided to bury the information.

Related article:  Viewpoint: Vodka is a known carcinogen. Who cares if Smirnoff makes it GMO-free?

“The message of 40 years of scientific studies is clear: this cancer is not caused by glyphosate,” Monsanto’s lawyer George Lombardi said, according to an online broadcast of the trial by Courtroom View Network.

If it finds Monsanto liable, the jury can decide to award punitive damages on top of the more than $39 million in compensatory damages Johnson demanded. The jury is expected to start deliberating on [August 8th].

Read full, original article: First trial alleging Monsanto’s Roundup causes cancer goes to jury

The GLP aggregated and excerpted this article to reflect the diversity of news, opinion, and analysis. Click the link above to read the full, original article.

3 thoughts on “Monsanto Roundup trial: First lawsuit alleging glyphosate-cancer link goes to jury”

  1. Glyphosphate/ organophosphste i believe causes epigenetic as well as genomic abnormalities that may result to carcinogenesis ad well as neurological deficits. However, may depend on the integrity of repair genes as well as the dose of such chemicals ingested, again, dosages may very from individual to individual.

Leave a Comment

News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend